Back to results

University of Bradford

Characterisation of Small Ubiquitin-like Modifier (SUMO) protein complex expression in human cancer cells to identify novel therapeutic targets

Abstract

dc:description.abstract

SUMOylation is a post-translational modification where a number of small ubiquitin-like modifier proteins (SUMO) are conjugated to lysine residues of the target proteins and contribute to various cellular functions essential for cancer cell survival and proliferation. The unique behaviours, phenotypic and molecular adaptations found in the naked-mole rat (NMR) suggest a high stability and effective functioning of the molecular machinery that counteracts damage accumulation in its genome. NMR can reach 32 years, shows no signs of ageing, and possesses a very efficient mechanism of resistance to cancer. This study aims to investigate the regulation of SUMOylation machinery between NMR tissues in comparison to human cancer cells, to find novel targets for cancer therapy. Gene expression of SUMO isoforms between NMR and humans, were investigated through qRT-PCR. The data suggests a significant low expression level for most SUMO machinery (except PIAS4) in NMR brain and intestine tissues compared to MCF-7, DLD-1, SH-SY5Y, and MCF-10A cells. Western blotting analysis also revealed high protein expression of PIAS4 in NMR compared to SENP1 and Ubc9. SUMO machinery expression levels from NMR are recapitulated in cancer cells either by silencing (hUBE2I: shRNA, hSENP1: shRNA) or overexpression (Myc/hPIAS4: Exp) to study functional effects. Cytotoxicity assays were analysed in relevance to Doxorubicin in MCF-7, 5-Fluorouracil in DLD-1 and Methotrexate in SH-SY5. Additionally, functional clonogenic and invasion assays were performed including apoptotic mechanisms (Bcl-2, and BID). In conclusion, the data revealed important differences in SUMOylation machinery between NMR and human cancer cells, which provides a future therapeutic path for cancer treatment.

Degree

thesis:*
Grantor dc:publisher.institution
University of Bradford

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Salih, Mohammed A.M.
Advisors dc:contributor.advisor
  • Kantamneni, Sriharsha
  • Williamson, Ritchie

Subjects

dc:subject × 11

Rights

dc:rights
Statement dc:rights
  • <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="Creative Commons License" style="border-width:0" src="http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png" /></a><br />The University of Bradford theses are licenced under a <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Licence</a>.
Language dc:language.iso
en

Identifiers

dc:identifier.*
Repository record dc:identifier.uri
https://bradscholars.brad.ac.uk/handle/10454/20583
OAI identifier oai:identifier
oai:bradscholars.brad.ac.uk:10454/20583

Chain of custody

source
Harvested from
University of Bradford
Base URL
bradscholars.brad.ac.uk/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Salih, Mohammed A.M.. Characterisation of Small Ubiquitin-like Modifier (SUMO) protein complex expression in human cancer cells to identify novel therapeutic targets. University of Bradford, https://bradscholars.brad.ac.uk/handle/10454/20583